Market cap
₹6 Cr
Revenue (TTM)
₹1 Cr
P/E Ratio
36.7
P/B Ratio
0.2
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -69.17 | -44.32 | -51.89 | -15.28 | -7.60 |
| EBIT | 550.00 | 18.18 | -35.01 | 31.74 | 17.45 |
| Net Profit | 541.67 | 16.67 | -51.89 | -15.28 | -7.60 |
| EPS | 547.37 | 16.59 | -35.64 | 30.83 | 17.62 |
| Book Value | -- | -- | 0.61 | 0.59 | 0.53 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Mar-25 | Mar-24 |
| EBIT-Margin
| 4.91 | -3.95 | 15.64 | 9.24 | 0.47 |
| Net Margin
| 5.32 | 5.15 | 11.64 | 6.93 | 5.05 |
| Return on equity
| 0.59 | 0.49 | 0.51 | 0.61 | 0.66 |
| Return on Capital
| 0.77 | 0.64 | -- | 0.82 | 0.79 |
| Return on Assets
| 0.58 | 0.47 | 0.51 | 0.60 | 0.64 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.00 | 0.00 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Symbiox Investment
|
--
|
0.82
|
0.79
|
0.69
|
0.60
|
|
Peer Median
|
--
|
2.98
|
1.57
|
3.43
|
--
|
ROE
0.51
Lower than Peers by 2.15
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Symbiox Investment
|
0.51
|
0.61
|
0.66
|
0.51
|
0.45
|
|
Peer Median
|
2.66
|
1.60
|
1.07
|
1.58
|
--
|
ROA
0.51
Lower than Peers by 0.92
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Symbiox Investment
|
0.51
|
0.60
|
0.64
|
0.49
|
0.43
|
|
Peer Median
|
1.43
|
1.16
|
0.66
|
1.55
|
--
|
EBIT Margin
15.64
Higher than Peers by 6.89
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Symbiox Investment
|
15.64
|
9.24
|
0.47
|
5.00
|
9.56
|
|
Peer Median
|
8.75
|
19.21
|
2.00
|
4.97
|
--
|
Net Margin
11.64
Higher than Peers by 0.74
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Symbiox Investment
|
11.64
|
6.93
|
5.05
|
3.98
|
7.54
|
|
Peer Median
|
10.91
|
36.43
|
18.36
|
44.25
|
--
|
Cash Profit Margin
0.00
Higher than Peers by 0.00
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Symbiox Investment
|
0.00
|
7.05
|
5.40
|
4.00
|
7.59
|
|
Peer Median
|
0.00
|
0.00
|
0.00
|
0.00
|
--
|
Revenue Growth
-51.89
Lower than Peers by 76.23
Year on year growth in net sales
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Symbiox Investment
|
-51.89
|
-29.10
|
-2.12
|
117.60
|
-11.96
|
|
Peer Median
|
24.34
|
329.40
|
5.65
|
61.99
|
--
|
EBIT Growth
-35.01
Lower than Peers by 53.84
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Symbiox Investment
|
-35.01
|
1,297.40
|
-90.83
|
13.87
|
119.13
|
|
Peer Median
|
18.83
|
2.93
|
-21.86
|
88.06
|
--
|
Net Profit Growth
-51.89
Lower than Peers by 91.25
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Symbiox Investment
|
-51.89
|
-7.86
|
30.88
|
14.57
|
100.12
|
|
Peer Median
|
39.36
|
20.55
|
-9.52
|
65.30
|
--
|
EPS Growth
-35.64
Lower than Peers by 87.28
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Symbiox Investment
|
-35.64
|
-7.96
|
30.84
|
14.64
|
100.00
|
|
Peer Median
|
51.64
|
20.51
|
--
|
--
|
--
|
Book Value Growth
--
--
Year on year growth in book value per share
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Symbiox Investment
|
--
|
0.61
|
0.66
|
0.50
|
0.66
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Symbiox Investment
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
319.64
Higher than Peers by 313.67
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Symbiox Investment
|
319.64
|
113.72
|
88.32
|
22.06
|
43.27
|
|
Peer Median
|
5.97
|
4.40
|
3.48
|
23.42
|
--
|
Quick Ratio
313.30
Higher than Peers by 308.01
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Symbiox Investment
|
313.30
|
109.11
|
88.07
|
21.92
|
43.27
|
|
Peer Median
|
5.29
|
14.44
|
6.30
|
130.13
|
--
|
Interest Coverage
--
--
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Symbiox Investment
|
--
|
564.45
|
340.06
|
1,215.76
|
--
|
|
Peer Median
|
77.14
|
64.71
|
28.80
|
111.04
|
--
|
Operating Efficiency
Debtors to sales
20.43
Higher than Peers by 10.20
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Symbiox Investment
|
20.43
|
5.65
|
0.39
|
20.02
|
47.40
|
|
Peer Median
|
10.23
|
35.56
|
42.54
|
1,459.31
|
--
|
Asset Turnover
0.04
Lower than Peers by 0.20
Sales / Average Total Assets
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Symbiox Investment
|
0.04
|
0.09
|
0.12
|
0.12
|
0.06
|
|
Peer Median
|
0.24
|
0.34
|
0.09
|
0.04
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Symbiox Investment
|
--
|
11.33
|
38.05
|
76.30
|
86.54
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Symbiox Investment
|
--
|
91.53
|
13.94
|
19.07
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Symbiox Investment
|
--
|
30.52
|
80.46
|
108.94
|
466.05
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Symbiox Investment
|
--
|
72.34
|
-28.48
|
-13.58
|
-379.51
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
36.66
Lower than Peers by 1.28
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Symbiox Investment
|
36.66
|
52.04
|
40.99
|
67.98
|
110.36
|
|
Peer Median
|
37.94
|
56.57
|
231.00
|
29.37
|
--
|
Price / Book Value
0.19
Lower than Peers by 3.46
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Symbiox Investment
|
0.19
|
0.31
|
0.27
|
0.35
|
0.49
|
|
Peer Median
|
3.65
|
1.47
|
2.60
|
0.64
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Symbiox Investment
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
21.54
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Symbiox Investment
|
21.54
|
33.97
|
32.88
|
47.68
|
80.67
|
|
Peer Median
|
--
|
13.55
|
14.22
|
4.39
|
--
|
Market Cap
6
Lower than Peers by 256
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Symbiox Investment
|
6
|
10
|
9
|
11
|
15
|
|
Peer Median
|
262
|
62
|
44
|
46
|
--
|